Some antibody medicines, including Ronapreve, may not be effective against the highly mutated omicron variant of the coronavirus, according to researchers at Japanese and U.S. institutes.
The findings by Yoshihiro Kawaoka, a professor of virology at the University of Tokyo's Institute of Medical Science, and others were published in the New England Journal of Medicine on Wednesday.
Unable to view this article?
This could be due to a conflict with your ad-blocking or security software.
Please add japantimes.co.jp and piano.io to your list of allowed sites.
If this does not resolve the issue or you are unable to add the domains to your allowlist, please see out this support page.
We humbly apologize for the inconvenience.